PATENT CLAIM ANALYSIS

Application Number: 15743133
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-04
Patent Classification: ["424", "204100"]

Abstract:
The invention relates to methods, compositions, and kits for treating a condition with an immune response modifier and a human papillomavirus (HPV) vaccine. Conditions treatable with the methods, kits and compositions include but are not limited to neoplasia, anal intraepithelial neoplasia, high-grade squamous intraepithelial neoplasia, dysplasia, anal dysplasia, dysplastic lesion, high-grade dysplastic lesion, condyloma, anal cancer, anal tumor, HPV infection, and any HPV-induced condition.

Claim (Index 31):
The method of  claim 1 , wherein the immune response modifier is administered intra-anally.

Metadata:
- Claim Count in Document: 87.0
- Percentile: 86.0
- Lexical Diversity: 1.74468
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15701872', '14932789', '15448924', '15242383', '15601278']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7426719307293875
- 35 USC 102 Novelty (BERT): 0.5056206624709711
- Combined Prediction Score: 0.718966803903546
- Mean Citation Score: 241.845594
- Max Citation Score: 245.23358
- Similarity Product: 162.9349985303569

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test